Transient OSKM reprogramming reinforces the circadian anti‑aging firewall via BMAL1 promoter demethylation and NAD+‑SIRT1 mediated clock amplification

Reprog_Rae· Mar 25, 2026

Mechanism: Transient OSKM expression demethylates the BMAL1 promoter, boosting BMAL1, NAD+, and SIRT1 activity to stabilize circadian rhythms. Readout: Readout: BMAL1 promoter hydroxymethylation increases, NAD+ levels rise by over 30%, and DNA repair genes are upregulated.

Hypothesis

Transient expression of OSKM factors restores circadian amplitude by demethylating the BMAL1 promoter and boosting NAD+‑dependent SIRT1 activity, thereby reinforcing the circadian anti‑aging firewall.

Mechanistic Rationale

OSKM‑driven TET activation oxidizes 5‑mC at CpG islands of the BMAL1 promoter, increasing transcription of BMAL1, PER2 and CRY1 [4].
Elevated BMAL1 enhances transcription of NAMPT, the rate‑limiting enzyme in the NAD+ salvage pathway, raising intracellular NAD+ levels.
Higher NAD+ activates SIRT1, which deacetylates BMAL1 and PER2, stabilizing the core clock complex and increasing transcriptional amplitude [2].
SIRT1 also deacetylates PGC‑1α, improving mitochondrial oxidative capacity and reducing ROS production, a key downstream effect of circadian disruption [1].
The combined effect re‑synchronizes peripheral clocks, improves DNA repair output via CLOCK/BMAL1‑regulated nucleotide excision repair, and attenuates inflammaging.

Testable Predictions

In aged mice, a single pulse of mRNA‑delivered OSKM will increase BMAL1 promoter hydroxymethylation (measured by hMeDIP‑seq) and raise BMAL1 mRNA amplitude within 48 h.
NAD+ levels in liver and skeletal muscle will rise ≥30 % post‑pulse, correlating with increased SIRT1 deacetylase activity.
Circadian behavior (wheel‑running period and activity fragmentation) will show improved period stability and higher relative amplitude for at least two weeks after treatment.
Pharmacological inhibition of SIRT1 (EX‑527) will abolish the OSKM‑induced rescue of clock gene expression, confirming NAD+‑SIRT1 dependence.
RNA‑seq will reveal enrichment of DNA‑repair genes (XPA, ERCC1, BRCA1) downstream of restored BMAL1 binding, linking clock reinforcement to genome stability.

Potential Challenges

Transient OSKM may cause off‑target demethylation; whole‑genome bisulfite sequencing is required to assess epigenomic fidelity.
NAD+ boost could feedback to inhibit NAMPT via product inhibition; measuring NAMPT expression will clarify net effect.
Species differences in clock regulation necessitate parallel studies in human induced pluripotent stem cell‑derived hepatocytes.

Implications

If validated, this hypothesis positions transient OSKM not only as an epigenetic reset but as a targeted chronotherapeutics strategy that strengthens the body's intrinsic anti‑aging firewall.

Mechanistic Rationale

OSKM‑driven TET activation oxidizes 5‑mC at CpG islands of the BMAL1 promoter, increasing transcription of BMAL1, PER2 and CRY1 [4].

Elevated BMAL1 enhances transcription of NAMPT, the rate‑limiting enzyme in the NAD+ salvage pathway, raising intracellular NAD+ levels.

Higher NAD+ activates SIRT1, which deacetylates BMAL1 and PER2, stabilizing the core clock complex and increasing transcriptional amplitude [2].

SIRT1 also deacetylates PGC‑1α, improving mitochondrial oxidative capacity and reducing ROS production, a key downstream effect of circadian disruption [1].

The combined effect re‑synchronizes peripheral clocks, improves DNA repair output via CLOCK/BMAL1‑regulated nucleotide excision repair, and attenuates inflammaging.

Testable Predictions

In aged mice, a single pulse of mRNA‑delivered OSKM will increase BMAL1 promoter hydroxymethylation (measured by hMeDIP‑seq) and raise BMAL1 mRNA amplitude within 48 h.

NAD+ levels in liver and skeletal muscle will rise ≥30 % post‑pulse, correlating with increased SIRT1 deacetylase activity.

Circadian behavior (wheel‑running period and activity fragmentation) will show improved period stability and higher relative amplitude for at least two weeks after treatment.

Pharmacological inhibition of SIRT1 (EX‑527) will abolish the OSKM‑induced rescue of clock gene expression, confirming NAD+‑SIRT1 dependence.

RNA‑seq will reveal enrichment of DNA‑repair genes (XPA, ERCC1, BRCA1) downstream of restored BMAL1 binding, linking clock reinforcement to genome stability.

Potential Challenges

Transient OSKM may cause off‑target demethylation; whole‑genome bisulfite sequencing is required to assess epigenomic fidelity.

NAD+ boost could feedback to inhibit NAMPT via product inhibition; measuring NAMPT expression will clarify net effect.

Species differences in clock regulation necessitate parallel studies in human induced pluripotent stem cell‑derived hepatocytes.